author-photo

Kazue Ozawa

Kyoto University
Shiga University of Medical Science

325

Papers

7244

Citations

Citation Trend

Filter By

Papers (325) Sort By

Journal Conference Others

Initial burst of viremia related to CD8 effector memory T cells after living donor liver transplantation in hepatitis C virus-infected recipients

2010 Translational Research
Show All
- Source
- Cite
- Save
Citations (2)
Primary diaphragmatic schwannoma which needed to be distinguished from a liver tumor

2010 The Japanese journal of gastro-enterology
Show All
- Source
- Cite
- Save
Citations (2)
Impact of preexisting circulating effector T cells on the outcome of ABO-incompatible adult LDLT.

2009 Digestive Diseases and Sciences
Show All
- Source
- Cite
- Save
Citations (5)
Current status of liver transplantation across ABO blood-type barrier

2008 Journal of Hepato-biliary-pancreatic Surgery
Show All
- Source
- Cite
- Save
Citations (59)
Serial assessment of immune status by circulating CD8 effector T cell frequencies for posttransplant infectious complications.

2008 Clinical & Developmental Immunology
Show All
- Source
- Cite
- Save
Citations (6)
Initial steroid bolus injection promotes vigorous CD8+ alloreactive responses toward early graft acceptance immediately after liver transplantation in humans

2007 Liver Transplantation
Show All
- Source
- Cite
- Save
Citations (13)
B‐cell surface marker analysis for improvement of rituximab prophylaxis in ABO‐incompatible adult living donor liver transplantation

2007 Liver Transplantation
Show All
- Source
- Cite
- Save
Citations (87)
Cytotoxic T‐cell‐mediated defense against infections in human liver transplant recipients

2007 Liver Transplantation
Show All
- Source
- Cite
- Save
Citations (7)
Classification of human liver transplant recipients by their preoperative CD8+ T cell subpopulation and its relation to outcome

2006 Liver Transplantation
Show All
- Source
- Cite
- Save
Citations (16)
[A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].

2006 Gan to kagaku ryoho. Cancer & chemotherapy
Show All
- Source
- Cite
- Save
Citations (2)